Fig. 2From: Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastomaa Profiles of differentially expressed genes (n = 86) between high- and non-high-risk groups. b GSVA score of gene sets significantly associated with risk group (n = 44)Back to article page